메뉴 건너뛰기




Volumn 18, Issue 7, 2016, Pages 678-684

Pharmacokinetics and pharmacodynamics of dapagliflozin in children and adolescents with type 2 diabetes mellitus

Author keywords

dapagliflozin; paediatric; pharmacodynamics; pharmacokinetics; type 2 diabetes mellitus

Indexed keywords

DAPAGLIFLOZIN; GLUCOSE; 2-(3-(4-ETHOXYBENZYL)-4-CHLOROPHENYL)-6-HYDROXYMETHYLTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; ANTIDIABETIC AGENT; BENZHYDRYL DERIVATIVE; GLUCOSE BLOOD LEVEL; GLUCOSIDE; SODIUM GLUCOSE COTRANSPORTER;

EID: 84974738135     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12638     Document Type: Article
Times cited : (21)

References (26)
  • 1
    • 0034088992 scopus 로고    scopus 로고
    • Type 2 diabetes in children and adolescents
    • American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23: 381–389.
    • (2000) Diabetes Care , vol.23 , pp. 381-389
  • 2
    • 3042760009 scopus 로고    scopus 로고
    • Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop
    • Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004; 27: 1798–1811.
    • (2004) Diabetes Care , vol.27 , pp. 1798-1811
    • Alberti, G.1    Zimmet, P.2    Shaw, J.3    Bloomgarden, Z.4    Kaufman, F.5    Silink, M.6
  • 4
    • 1842537887 scopus 로고    scopus 로고
    • Type 2 diabetes in the young: the evolving epidemic
    • Bloomgarden ZT. Type 2 diabetes in the young: the evolving epidemic. Diabetes Care 2004; 27: 998–1010.
    • (2004) Diabetes Care , vol.27 , pp. 998-1010
    • Bloomgarden, Z.T.1
  • 5
    • 84873519427 scopus 로고    scopus 로고
    • Prevalence of hyperinsulinism, type 2 diabetes mellitus and metabolic syndrome among Saudi overweight and obese pediatric patients
    • Al-Agha A, Ocheltree A, Shata N. Prevalence of hyperinsulinism, type 2 diabetes mellitus and metabolic syndrome among Saudi overweight and obese pediatric patients. Minerva Pediatr 2012; 64: 623–631.
    • (2012) Minerva Pediatr , vol.64 , pp. 623-631
    • Al-Agha, A.1    Ocheltree, A.2    Shata, N.3
  • 6
    • 84908221121 scopus 로고    scopus 로고
    • Joining forces: a call for greater collaboration to study new medicines in children and adolescents with type 2 diabetes
    • Karres J, Pratt V, Guettier JM et al. Joining forces: a call for greater collaboration to study new medicines in children and adolescents with type 2 diabetes. Diabetes Care 2014; 37: 2665–2667.
    • (2014) Diabetes Care , vol.37 , pp. 2665-2667
    • Karres, J.1    Pratt, V.2    Guettier, J.M.3
  • 7
    • 0038100206 scopus 로고    scopus 로고
    • Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents
    • Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003; 88: 1417–1427.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 1417-1427
    • Goran, M.I.1    Ball, G.D.2    Cruz, M.L.3
  • 8
    • 84873479807 scopus 로고    scopus 로고
    • Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents
    • Copeland KC, Silverstein J, Moore KR et al. Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents. Pediatrics 2013; 131: 364–382.
    • (2013) Pediatrics , vol.131 , pp. 364-382
    • Copeland, K.C.1    Silverstein, J.2    Moore, K.R.3
  • 9
    • 41649087328 scopus 로고    scopus 로고
    • Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
    • Meng W, Ellsworth BA, Nirschl AA et al. Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. J Med Chem 2008; 51: 1145–1149.
    • (2008) J Med Chem , vol.51 , pp. 1145-1149
    • Meng, W.1    Ellsworth, B.A.2    Nirschl, A.A.3
  • 10
    • 84891878819 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2
    • Kasichayanula S, Liu X, LaCreta F, Griffen SC, Boulton DW. Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2. Clin Pharmacokinet 2014; 53: 17–27.
    • (2014) Clin Pharmacokinet , vol.53 , pp. 17-27
    • Kasichayanula, S.1    Liu, X.2    LaCreta, F.3    Griffen, S.C.4    Boulton, D.W.5
  • 12
    • 84976585919 scopus 로고    scopus 로고
    • Accessed 31 July 2015
    • European Medicines Agency. Forxiga summary of product characteristics. Available from URL: http://ec.europa.eu/health/documents/community-register/2012/20121112124487/anx_124487_en.pdf. Accessed 31 July 2015.
    • Forxiga summary of product characteristics
  • 13
    • 84974736701 scopus 로고    scopus 로고
    • Study NCT01525238. Accessed 31 July 2015
    • ClinicalTrials.gov. PK study of dapagliflozin in pediatric subjects with T2DM. Study NCT01525238. Available from URL: https://clinicaltrials.gov/ct2/show/NCT01525238. Accessed 31 July 2015.
    • PK study of dapagliflozin in pediatric subjects with T2DM
  • 14
    • 58549090937 scopus 로고    scopus 로고
    • World Health Organization Web site. Accessed 30 June 2015
    • World Health Organization/International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. World Health Organization Web site. Available from URL: http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed 30 June 2015.
    • Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia
  • 15
    • 75149130955 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl. 1): S62–S69.
    • (2010) Diabetes Care , vol.33 , pp. S62-S69
  • 16
    • 62149125881 scopus 로고    scopus 로고
    • New equations to estimate GFR in children with CKD
    • Schwartz GJ, Munoz A, Schneider MF et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629–637.
    • (2009) J Am Soc Nephrol , vol.20 , pp. 629-637
    • Schwartz, G.J.1    Munoz, A.2    Schneider, M.F.3
  • 17
    • 84925002886 scopus 로고    scopus 로고
    • Selective reaction monitoring of negative electrospray ionization acetate adduct ions for the bioanalysis of dapagliflozin in clinical studies
    • Ji QC, Xu X, Ma E et al. Selective reaction monitoring of negative electrospray ionization acetate adduct ions for the bioanalysis of dapagliflozin in clinical studies. Anal Chem 2015; 87: 3247–3254.
    • (2015) Anal Chem , vol.87 , pp. 3247-3254
    • Ji, Q.C.1    Xu, X.2    Ma, E.3
  • 18
    • 67349275999 scopus 로고    scopus 로고
    • Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus
    • Komoroski B, Vachharajani N, Feng Y, Li L, Kornhauser D, Pfister M. Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus. Clin Pharmacol Ther 2009; 85: 513–519.
    • (2009) Clin Pharmacol Ther , vol.85 , pp. 513-519
    • Komoroski, B.1    Vachharajani, N.2    Feng, Y.3    Li, L.4    Kornhauser, D.5    Pfister, M.6
  • 19
    • 0026499896 scopus 로고
    • Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement
    • Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55: 615S–619S.
    • (1992) Am J Clin Nutr , vol.55 , pp. 615S-619S
  • 20
    • 33750107067 scopus 로고    scopus 로고
    • The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study
    • Liese AD, D'Agostino RB Jr, Hamman RF et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006; 118: 1510–1518.
    • (2006) Pediatrics , vol.118 , pp. 1510-1518
    • Liese, A.D.1    D'Agostino, R.B.2    Hamman, R.F.3
  • 21
    • 84899869077 scopus 로고    scopus 로고
    • Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009
    • Dabelea D, Mayer-Davis EJ, Saydah S et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014; 311: 1778–1786.
    • (2014) JAMA , vol.311 , pp. 1778-1786
    • Dabelea, D.1    Mayer-Davis, E.J.2    Saydah, S.3
  • 22
    • 84974720754 scopus 로고    scopus 로고
    • United States Census Bureau Web site. Accessed 3 September 2015
    • United States Census Bureau Quickfacts. United States Census Bureau Web site. Available from URL: http://quickfacts.census.gov/qfd/states/00000.html. Accessed 3 September 2015.
  • 23
    • 84873429530 scopus 로고    scopus 로고
    • Simultaneous oral therapeutic and intravenous (1)(4)C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin
    • Boulton DW, Kasichayanula S, Keung CF et al. Simultaneous oral therapeutic and intravenous (1)(4)C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin. Br J Clin Pharmacol 2013; 75: 763–768.
    • (2013) Br J Clin Pharmacol , vol.75 , pp. 763-768
    • Boulton, D.W.1    Kasichayanula, S.2    Keung, C.F.3
  • 24
    • 79955001140 scopus 로고    scopus 로고
    • The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver
    • Miyagi SJ, Collier AC. The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver. Drug Metab Dispos 2011; 39: 912–919.
    • (2011) Drug Metab Dispos , vol.39 , pp. 912-919
    • Miyagi, S.J.1    Collier, A.C.2
  • 25
    • 84862702300 scopus 로고    scopus 로고
    • Neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics
    • Miyagi SJ, Milne AM, Coughtrie MW, Collier AC. Neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics. Drug Metab Dispos 2012; 40: 1321–1327.
    • (2012) Drug Metab Dispos , vol.40 , pp. 1321-1327
    • Miyagi, S.J.1    Milne, A.M.2    Coughtrie, M.W.3    Collier, A.C.4
  • 26
    • 84974674472 scopus 로고    scopus 로고
    • Comparison of the exposure-response relationship of dapagliflozin in adult and paediatric patients with type 2 diabetes mellitus
    • Parkinson J, Tang W, Johansson C-C, Boulton DW, Hamrén B. Comparison of the exposure-response relationship of dapagliflozin in adult and paediatric patients with type 2 diabetes mellitus. Diabetes Obes Metab 2016; 18: 685–692.
    • (2016) Diabetes Obes Metab , vol.18 , pp. 685-692
    • Parkinson, J.1    Tang, W.2    Johansson, C.-C.3    Boulton, D.W.4    Hamrén, B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.